Novel Oral Anticoagulant Use Among Patients with Atrial Fibrillation Hospitalized with Ischemic Stroke or Transient Ischemic Attack

BACKGROUND: Novel oral anticoagulants (NOACs) have been shown to be at least as good as warfarin for preventing stroke or transient ischemic attack (TIA) in patients with atrial fibrillation (AF), yet diffusion of these therapies and patterns of use among AF patients with ischemic stroke and TIA hav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Cardiovasc Qual Outcomes
Main Authors: Patel, Priyesh A., Zhao, Xin, Fonarow, Gregg C., Lytle, Barbara L., Smith, Eric E., Xian, Ying, Bhatt, Deepak L., Peterson, Eric D., Schwamm, Lee H., Hernandez, Adrian F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4512906/
https://ncbi.nlm.nih.gov/pubmed/26058721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.114.000907
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados